Republic of Senegal and Team Europe agree to build a manufacturing plant to produce vaccines against COVID-19 and other endemic diseases

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


  • President of the Republic of Senegal, His Excellency Macky Sall, welcomes the support of Team Europe and other partners, including the United States and the World Bank Group, in the construction in Senegal of a facility for manufacturing vaccines against COVID-19 and other endemic diseases
  • President of the Republic of Senegal, European Commissioner for the Internal Market, European Investment Bank Director and United States sign grant agreements to set up large-scale vaccine production project
  • Part of the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa, set to reduce Africa’s dependence on 99% imported vaccines and bolster production in Africa
  • Project will significantly increase Africa’s medical and vaccine production capacity and reduce its dependence on imports, which account for 99 % of its vaccine needs
  • Institut Pasteur de Dakar to host regional manufacturing hub
  • Government of Senegal and international financing partners to support scheme

Producing COVID-19 vaccines in Africa came one step closer today after Team Europe formally agreed to support large-scale investment in vaccine production by the Institut Pasteur in Dakar, alongside other support measures. The new manufacturing plant should reduce Africa’s 99% dependence on vaccine imports and strengthen future pandemic resilience on the continent.

The agreement is part of a major package of investment in vaccine and pharmaceuticals production in Africa launched by Team Europe in May, which brings together the European Commission, EU Member States, and the European Investment Bank, and other financial institutions, in line with the EU’s Strategy with Africa and the strategy of the Africa Centres for Disease Control and Prevention (Africa CDC) and the Partnerships for African Vaccine Manufacturing (PAVM).

Team Europe, together with other international partners, has committed to a significant package of support for the medium- to long-term sustainability of the project. This includes: 

Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) is supporting the manufacturing hub in Senegal with a €20 million grant through KfW (Kreditanstalt für Wiederaufbau), the German development bank.

France, through the Agence Française de Développement (AFD), has already granted two initial financing packages totalling €1.8 million to the MADIBA project (Manufacturing in Africa for Disease Immunization and Building Autonomy) at the Pasteur Institute in Dakar for feasibility studies and initial investments. The AFD Group and its private sector subsidiary, Proparco, are also working within the group of technical and financial partners to structure the project in order to reach financial support at a larger scale.

Belgium will support Senegal in structuring initiatives to produce vaccines and pharmaceuticals, such as the Pharmapolis pharma hub. Belgium also welcomes the fact that a Belgian biotech company in novel bio-manufacturing platforms is forging, with the support of Wallonia, a partnership with the Institut Pasteur in Dakar, as a key partner for building capacity and transferring technology.

The European Commission is discussing with the Senegalese authorities the possibility of mobilising further financial support by the end of 2021 under the new NDICI / Global Europe instrument to support this project. This is part of the €1 billion Team Europe initiative to boost the manufacturing of, and access to, vaccines, medicines and health technologies in Africa, which European Commission President Ursula von der Leyen announced in May 2021.

At a ceremony at the Presidential Palace in Dakar, the President of the Republic of Senegal, His Excellence Macky Sall, European Commissioner for the Internal Market Thierry Breton and representatives of Germany, France, Belgium, the European Investment Bank and other development finance institutions, including the IFC, today confirmed details of Team Europe support to accelerate project preparation, expand manufacturing capacities and undertake technical feasibility work. These will be crucial to unlock large-scale investment in the new plant. This will be built over the next 18 months and will equip the African continent with a state-of-the-art facility for the production of authorised COVID-19 vaccines.

Today, Team Europe is providing €6.75 million in grant support to enable technical feasibility studies and project preparation for the new facility at the Institut Pasteur in Dakar. This amount includes €4.75 million from the European Commission and the European Investment Bank, €200,000 from Germany, and €1.8 million from France. This will also enable the total investment cost and financial structures to be defined and agreed with Senegalese and international partners. Construction of the new plant is expected to start later this year, with 25 million vaccine doses being produced each month by the end of 2022.

Partners and members of the college said

Announcing today’s contracts, Amadou Hott, Senegal’s Minister of the Economy said: “To strengthen the fight against pandemics in Africa, the Government of Senegal is committed to enabling COVID-19 vaccine production at the Institut Pasteur in Dakar. This project is part of the vision of His Excellency Macky Sall, President of the Republic of Senegal, to lay the foundations for the country’s – and the continent’s – pharmaceutical and medical sovereignty. It is strongly supported by my colleagues in charge of finance and health who see it as another means with which to tackle the COVID-19 pandemic more effectively. Initial funding and expertise from Team Europe and other partners, such as the United States, the World Bank Group, and regional donors, will accelerate construction of the new production plant, increase access to affordable vaccines in Africa, and enable vaccine production to rapidly respond to new pandemics.”

“Africa currently imports 99% of its vaccines. But with today’s agreement, Team Europe is helping Senegal move one important step closer to producing its own vaccines and protecting Africans from COVID-19 and other diseases. And more will come. This is just the first part of a much broader Team Europe initiative to support the production of medicines and vaccines across Africa,” said Commission President Ursula von der Leyen.

“Scaling up local production of COVID-19 vaccines is crucial to tackle the pandemic. As part of Team Europe, the European Investment Bank welcomes today’s agreement that will unlock large scale investment at the Institut Pasteur in Dakar to manufacture vaccines in Senegal and improve health across Africa. The European Investment Bank looks forward to even closer technical and financial cooperation with Senegalese and international partners to deliver this visionary project. This is a key milestone in the EIB’s global effort to address the health and economic challenges of COVID-19 and build a better future,” said Werner Hoyer, President of the European Investment Bank.

“Team Europe is proud to support the Government of Senegal’s visionary ambition to enable licensed COVID-19 vaccine production at the Institut Pasteur in Dakar. The initiative will not only support Africa’s autonomy in the production of life-saving vaccines, but also serve as an important building block in Senegal’s emergent health industrial ecosystem,” said Thierry Breton, Commissioner for the Internal Market, leading the European Commission’s task force for the industrial scale-up of vaccine production.

“Team Europe is mobilised to support African partners throughout the COVID-19 crisis, in line with the priorities in our Africa Strategy. Boosting local manufacturing of vaccines, medicines and health technologies is one of the key lessons of the pandemic. Today, we draw on our combined financial firepower and expertise to accompany Senegal and the Institut Pasteur of Dakar in producing vaccines to bring the pandemic to an end. It is crucial to take an integrated, 360-degree approach by further investing with our African partners in areas like the enabling environment, regulatory strengthening, incentives for the private sector, research and development, education and training, and innovative jobs,” said Jutta Urpilainen, Commissioner for International Partnerships.

“As part of Team Europe, the European Investment Bank is pleased to support technical feasibility and project preparation studies for Africa’s first COVID-19 vaccine manufacturing plant at the Institut Pasteur in Dakar. Over the coming months we will intensify cooperation with the Government of Senegal and international financing, technical and pharmaceutical partners to unlock large-scale financing to bring African vaccine production to reality and reduce Africa’s dependence on imported vaccines,” said Ambroise Fayolle, European Investment Bank Vice-President.

“COVID-19 poses a growing threat in Africa. So Africa needs a vaccine campaign – using African-produced vaccines. Now, for the first time, the continent has a realistic chance of establishing its own manufacturing facilities. Senegal’s Institut Pasteur has unveiled an actionable strategy for launching licensed COVID-19 vaccine production in Africa. The 20 million euros we are providing in seed funding will be important in helping to get the project off the ground. Germany supports the goal that Senegal and the international community share, which is for us to emerge from this pandemic stronger,” said Germany’s Minister for Development, Gerd Müller.

“Addressing vaccine production capacity is a key aspect of our strategy to stem the pandemic, as the President of the Republic has stated. Today, by supporting vaccine production in Africa with a European approach, we’re helping to build our partners’ ability to autonomously provide vaccines for their citizens. So I’m delighted to see this vaccine plant project take shape, a project that is the result of collaboration between the Pasteur Institute in Dakar, Senegal and Team Europe,” said the French Minister for Europe and for Foreign Affairs, Jean-Yves le Drian.

“We fully join Team Europe. Vaccine equality is key to my policy and a major global challenge. Africa needs access to affordable, quality-assured health products. Belgium’s efforts go beyond increasing vaccine manufacturing capacities. They shall prioritise public health, reinforce epidemic preparedness and strengthen local health systems. We will support our Senegalese partners with the structuring of their pharmaceutical industry and the launch of a pharma production hub,” said Belgium’s Minister of Development Cooperation and Major Cities Policy, Meryame Kitir.

Background

Team Europe has been at the forefront of the response to COVID-19 in Africa, as one of the leading donors to the COVAX Facility, the global initiative to secure fair and equitable access to COVID-19 vaccines in low and middle-income countries.

Institut Pasteur de Dakar key partner for vaccine production in Africa

The Institut Pasteur in Dakar already produces World Health Organisation approved vaccines and has been identified by the Government of Senegal and the Africa Centres for Disease Control and Protection as a potential host for the new vaccine production plant. The new facility is expected to be built on land adjacent to existing research facilities.

Following the signature ceremony at the presidential palace today, a delegation visited the Institut Pasteur de Dakar to discuss plans for vaccine production with Amadou Sall, General Administrator of the Institut Pasteur de Dakar. The European Investment Bank and Germany’s KfW development bank are already cooperating with the Institut Pasteur de Dakar to scale up production of rapid diagnostic testing kits for use by front-line health workers across Africa.

France is a long-standing partner of the network of Pasteur Institutes and in particular of the Pasteur Foundation in Dakar which it supports in its efforts to increase its vaccine production capacity. AFD has been co-financing the Africamaril project for the construction of a new yellow fever vaccine production plant in the new town of Diamniadio for over five years. This plant will complement the historical facilities of the Pasteur Foundation in Dakar which has been producing these vaccines since 1937. Equipped with extensive experience and due to this long-standing relationship, France is now supporting the Pasteur Institute of Dakar in this new stage in the fight against COVID-19, whose experience will be necessary to meet the current challenge of increasing local production capacities in Africa.

Reducing Africa’s dependence in vaccine imports

Africa, a continent of 54 countries and 1.2 billion people, currently produces only 1% of the vaccines it administers. The remaining 99% are imported.

The COVID-19 pandemic has further exposed Africa’s vulnerabilities in ensuring affordable access to vital drugs, vaccines and health technologies. Boosting local production will save lives, boost public health and health systems, and strengthen African economies, including supporting local jobs and enhance the sharing of crucial technologies.

African, European and international support for new facility

The first phase of the new vaccine production plant is expected to be financed by the Government of Senegal and international partners including the European Commission, through the European Investment Bank, Agence Française de Développement, Germany’s Federal Ministry for Economic Cooperation and Development (BMZ), the International Finance Corporation (IFC) and the US Development Finance Corporation (DFC). Leading pharmaceutical and technical partners are already working with the Institut Pasteur de Dakar to enable existing vaccine production, specialist packing and distribution technology to be used at the new plant. The European Commission is currently funding two projects to support the Institut Pasteur de Dakar.

Broader Team Europe support for health resilience in Africa

As Team Europe, the European Commission, European Investment Bank and European development finance partners are addressing Africa’s need to increase local manufacturing capacity to produce vaccines in order to bolster Africa’s health security.

Through the new Sustainable Health Industry for Resilience in Africa (SHIRA) scheme the EIB is providing financing and technical support to tackle barriers to regional production.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

How COVID-19 could open the door for driverless deliveries

4 steps to developing responsible AI

Capital markets selloff: The financial moguls send messages to monetary authorities

5 crises that could worsen under COVID-19

CEOs as activists: should leaders speak up about social causes?

Refugee crisis update: Commission is struggling alone with little help from EU or G7 leaders

Thursday’s Daily Brief: Albinism, displacement in Central America, family-friendly nations, updates on the Gulf and Darfur

This city is planting a tree for every man, woman and child

Belgium: keep up reforms to increase employment and productivity growth

COVID-19 : Have we learnt any lessons at all from last year?

Our poisonous air is harming our children’s brains

UN human rights chief fears world has grown numb to Syrian carnage

The European Green Deal must be at the heart of the COVID-19 recovery

EU and 15 World Trade Organization members establish contingency appeal arrangement for trade disputes

Mental health in times of a pandemic: what can each individual do to lessen the burden?

China revisited by the former Ambassador of Hungary to China

Coronavirus: Team Europe continues to deliver with more than €26 billion disbursed in support to partner countries in one year

Thousands returning to Nigeria’s restive Borno state ‘at risk’; UN ‘gravely concerned’

Russia and the West use the same tactics to dismember Ukraine

OECD Secretary-General Gurría welcomes announcement of new trade agreement between the US, Mexico and Canada

Iraq: Solutions needed ‘urgently’ to quell ongoing violence, break political deadlock

Brexit: No deal without marginalizing the hard Tory Eurosceptic MPs

Latin America’s cities are ready to take off. But their infrastructure is failing them

‘Bleakest period yet’ in Occupied Palestinian Territory: UN human rights expert

EU: All economic indicators in free fall

How do we upskill a billion people by 2030? Leadership and collaboration will be key

5 things you probably didn’t know about global health

A fairer world requires fairer tech. Here’s why

The world’s coastal cities are going under. Here’s how some are fighting back

The power of digital tools to transform mental healthcare

How has technology changed – and changed us – in the past 20 years?

The European Commission cuts roaming charges. But “it’s not enough”…

What have the banks done to the markets making them unable to bear cheap oil?

These 3 tech visionaries are reinventing the wheelchair

7 ways to break the fast fashion habit – and save the planet

Environmental liability rules need revamping

Fall asleep in Vienna, wake up in Paris – Europe’s night trains make a comeback

Human rights champions from across the world receive top UN prize

Young people worldwide can ‘determine the future of migration,’ says UN senior official

From violence to dialogue: as land conflicts intensify, UN boosts efforts to resolve disputes through mediation

How data is transforming the way we care for the ocean

European Fund for Transition to support more workers made redundant

The European Council takes more measures to stem illegal migration

Commission initiates an investigation to decide whether to prolong the steel safeguard measure

What’s the difference between carbon negative and carbon neutral?

Multilateralism’s ‘proven record of service’ is focus of first-ever International Day

Illness in health workers: when the caregiver becomes the patient

Ocean Conference has potential to be a ‘global game-changer’

An entrepreneurial point-of view on tackling the migration crisis and the risks of abolishing Schengen

Victims’ Rights: New Strategy to empower victims

Why the global trade of chemicals is key to COVID-19 recovery

An electric motorbike could help tackle big game poaching. Here’s how

Changing world of work needs new jobs strategy

Same-sex marriages and partnerships should be recognised across the EU

Poliomielitis: climatic changes and impossibility in border control

Working with millennials, leaders say humility works better than bossing around

To take or not to take – The Indian vaccination dilemma

Coronavirus global response: EU Humanitarian Air Bridge to Iraq and new funding

ECB readies itself for extraordinary monetary measures defying Germany

Cross-roads

More Stings?

Trackbacks

  1. […] Republic of Senegal and Team Europe agree to build a manufacturing plant to produce vaccines against… […]

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: